Keywords: schwarz, neupro, launched, uk, german, drugmaker, pharma
Schwarz' Neupro launched in the UK
Article | 10 April 2006
German drugmaker Schwarz Pharma's dopamine agonist Neupro (rotigotine transdermal patch), has been launched in the UK for early-stage Parkinson's disease.
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
